CAS: 1883510-31-3
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
ML327 REF: IN-DA01EB2BCAS: 1883510-31-3 | 95% | To inquire | Tue 10 Dec 24 | |
ML327 REF: TM-T4252CAS: 1883510-31-3 | 99.48% | 49.00 €~791.00 € | Tue 17 Dec 24 | |
ML327 REF: 3D-IAD51031CAS: 1883510-31-3 | Min. 95% | To inquire | Tue 21 Jan 25 |
Ref: IN-DA01EB2B
1mg | 116.00 € | ||
5mg | 261.00 € | ||
25mg | To inquire | ||
50mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
ML327
CAS:1883510-31-3
ML327 is a MYC blocker. ML327 can also de-repress E-cadherin transcription and reverse Epithelial-to-Mesenchymal Transition …
Formula:
C19H18N4O4
Purity:
99.48%
Color and Shape:
Solid
Molecular weight:
366.37
Ref: TM-T4252
1mg | 49.00 € | ||
5mg | 109.00 € | ||
10mg | 171.00 € | ||
25mg | 346.00 € | ||
50mg | 555.00 € | ||
100mg | 791.00 € | ||
1mL*10mM (DMSO) | 117.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
ML327
CAS:1883510-31-3
ML327 is a small molecule that has been shown to inhibit the growth of cancer …
Formula:
C19H18N4O4
Purity:
Min. 95%
Molecular weight:
366.37 g/mol
Ref: 3D-IAD51031
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025